Heranba Industries Limited (NSE:HERANBA)
India
· Delayed Price · Currency is INR | Market Cap | 8.93B |
| Revenue (ttm) | 16.10B |
| Net Income (ttm) | -600.90M |
| Shares Out | 40.01M |
| EPS (ttm) | -15.02 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | 1.00 (0.44%) |
| Ex-Dividend Date | Sep 17, 2025 |
| Volume | 32,277 |
| Average Volume | 99,880 |
| Open | 223.00 |
| Previous Close | 225.97 |
| Day's Range | 220.10 - 228.89 |
| 52-Week Range | 155.38 - 403.70 |
| Beta | 0.25 |
| RSI | 65.02 |
| Earnings Date | May 26, 2026 |
About Heranba Industries
Heranba Industries Limited manufactures and sells various agrochemicals in India and internationally. It offers intermediates, such as cypermethric acid chloride (CMAC), high CIS CMA and CMAC, high trans CMA and CMAC, bromobenzenes, metaphenoxy benzaldehyde and benzyl alcohol, and NPBR; and insecticides, including cypermethrin, deltamethrin, alpha cypermethrin, tolfenpyrad, lambda cyhalothrin, permethrin, profenophos, dinotefuran, temephos, theta cypermethrin, diflubenzuron, ethion, methamidophos, thiophanate-methyl, and bifenthrin. The company... [Read more]
Financial Performance
In fiscal year 2025, Heranba Industries's revenue was 14.10 billion, an increase of 12.14% compared to the previous year's 12.57 billion. Earnings were 30.70 million, a decrease of -91.20%.
Financial StatementsNews
Heranba Industries subsidiary begins commercial production at Sarigam Unit, Phase-II
Heranba Industries has announced that its wholly owned subsidiary, Heranba Organics Private Limited (HOPL), has officially started commercial production at its Sarigam Unit Phase-II, located in GIDC, ...